Candidozyma (formerly Candida) auris (C. auris), a WHO critical priority pathogen known for its multi-drug resistance and strong skin tropism, is posing a significant health threat. This study evaluates the efficacy of commercial octenidine-based antiseptics in reducing C. auris colonisation on intact and wounded human skin. Using an established ex vivo human skin model to simulate clinical settings, skin samples from healthy donors were exposed to planktonic C. auris cells. Six hours post-contamination, two ready-to-use octenidine-based antiseptics were applied, and fungal colonisation was assessed after 18 h via periodic acid-Schiff staining, bright field and scanning electron microscopy and colony forming unit quantification. In vitro biofilm assays with various C. auris strains, including drug resistant ones, were performed to determine the antifungal effects of octenidine formulations. Results showed that octenidine-based antiseptics significantly reduced C. auris viability on intact and wounded human skin, and also demonstrated a nearly complete eradication across tested strains in vitro. These findings highlight the potential of octenidine-based products in reducing C. auris colonisation, supporting infection prevention and control strategies in healthcare settings and enhancing patient safety.
Summary: Parallel to the increasing dissemination of electronic cigarettes (E-cigarette) in the population, increasing numbers of burn injuries caused by explosions of the devices or the rechargeable lithium-ion batteries have been observed worldwide. Several cases of E‑cigarette-related explosions have already resulted in fatalities. We report a series of 7 patients who were treated at our department between 2016 and 2022. Of the seven patients two required treatment in the intensive care unit (ICU), two further patients required normal ward and three patients could be treated as outpatients. The median age of the patients was 43 years and the female to male ratio 2:5. Most of the patients had superficial to full thickness burn injuries on their thighs and (dominant) hands; however, injuries to the genitals were also observed. The patients’ burns had a median total body surface area of 4.5%. Of these patients 4 had to stay in hospital for a median of 12.5 days, 2 of them required surgical treatment and intensive care. No patient died during hospitalization. Explosions of E‑cigarettes often happen in public while the devices or rechargeable lithium-ion batteries are being carried in trouser pockets, as shown in our study. This often ignites the victim’s clothing. In a crowd or on public transport, this fire could spread quickly and endanger surrounding persons. It is therefore in the public interest to raise awareness of this potential danger from E‑cigarettes.
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare lymphoma primarily linked to textured breast implants. Symptoms are often non-specific (e.g., breast swelling, pain, or fluid collection). When imaging detects fluid around the implant, cytological examination is the first diagnostic approach. However, this method has limited sensitivity and may yield false-negative results. In this case, a 41-year-old woman presented with swelling, pain, and itching in her left breast six years after bilateral textured breast implant placement. Ultrasonography (US) revealed peri-implant fluid collection around the left implant. A following magnetic resonance imaging (MRI) scan ruled out an implant rupture. Due to persistent pain and the peri-implant effusion on the left side, open surgery was performed. During implant removal, the seroma was drained, and multiple suspicious masses were found on the left side. The cytology of the seroma fluid was negative and intraoperative frozen sections of the excised masses were inconclusive. A complete capsulectomy was conducted due to the suspicion of malignancy. Histological examination ultimately confirmed the diagnosis of BIA-ALCL. This case highlights the diagnostic challenges associated with this rare condition. Therefore, BIA-ALCL should always be considered in the differential diagnosis of breast implant-associated seroma.
26 June 2026 in Journal of Investigative Dermatology
Candida auris (C. auris) is an emerging fungal pathogen with a remarkable ability to persist on human skin, but how structural skin cells respond to colonization is unclear. We used ex vivo human skin models, together with primary keratinocytes and fibroblasts, to characterize epithelial and stromal responses to C. auris compared with Candida albicans. C. auris formed biofilms and induced a wound-model-dependent pattern of cytokine secretion dominated by IL-1β and IL-6, yet caused minimal epithelial damage and modest reductions in leukocyte viability. RNA sequencing revealed complementary but cell-type-specific responses. Keratinocytes and fibroblasts both amplified a pro-inflammatory IL-6/CXCL8 response, while keratinocytes additionally upregulated antimicrobial genes such as RNASE7, TSLP, DEFB103A (encoding hBD-3), and the neutrophil-recruiting chemokines CXCL2 and CXCL3. Fibroblasts further induced CCL28, supporting T cell recruitment, alongside transcriptional programs associated with tissue remodeling. Recombinant RNase 7 and short form TSLP directly inhibited C. auris growth in vitro in a dose-dependent manner. Together, these findings identify keratinocytes as epithelial sentinels that integrate inflammatory and antimicrobial defenses against skin-tropic C. auris and suggest that fibroblast-driven cytokine amplification and especially antimicrobial peptides from within the skin barrier may provide therapeutic targets to limit C. auris skin colonization.
Background: In recent years, the number of patients seeking body contouring surgeries after a single organ transplantation has increased due to better postoperative care, better immunosuppressive regimens and the advancement of laparoscopic bariatric surgical techniques. In these patients, body contouring procedures can improve function, aesthetics, and overall quality of life and are offered to a greater number of patients including cohorts with significant medical comorbidities such as immunosuppression after solid organ transplantation. Therefore, in this case series, we explored the topic of body contouring surgery in patients who underwent solid organ transplantation. Methods: In this retrospective study, we included patients who underwent a single organ transplantation prior to a body contouring surgery between 2010 and 2021. Inclusion criteria were age over 18 years, a body contouring surgery at our center, a single organ transplantation before the body contouring procedure and a postoperative follow up of four weeks or more. Results: A total of 422 patients underwent body contouring procedures in our center. After excluding non-eligible patients, four patients were recruited. Overall, four complications in three patients occurred, ranging from Grade I to II according to the Dindo and Clavien classification for surgical complications. Conclusions: Body contouring surgery seems to be safe in patients with single organ transplantation. However, careful patient selection in a multidisciplinary team is required to ensure patients’ safety and favorable postoperative outcomes in patients with extended operative indications and significant comorbidities such as solid organ transplantation and immunosuppression. Complex patients should be treated in close collaboration with transplant surgery and internal medicine at a tertiary center.